Company / Cash per Share
Corcept Therapeutics Incorporated Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.15
FY2025
5-year range
$0.63 / $1.26
FY2021-FY2025
Trend
-7.1%
vs FY2024
Sector context
#139 of 205
Health Care
What the data says
At $1.15, Corcept Therapeutics Incorporated's cash per share ranks #139 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $0.22 in FY2016 to $1.26 in FY2023.
Based on SEC 10-K filings.
1.15 in FY2025 with a 5-year CAGR of +11.5%.
Declined from $1.26 to $1.15 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +22.3%
- 5-Year CAGR
- +11.5%
- 10-Year CAGR
- -
Sector benchmark
#139 of 205 in Health CareTop 68% of 205This company $1.15 Sector average $67.98
▼
-98.3% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 7.1% year-over-year.
- Ranks #139 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2023.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.15 | -7.1% |
| FY2024 | $1.23 | -1.8% |
| FY2023 | $1.26 | +100.8% |
| FY2022 | $0.63 | -5.8% |
| FY2021 | $0.66 | -0.0% |
| FY2020 | $0.67 | +144.7% |
| FY2019 | $0.27 | -39.5% |
| FY2018 | $0.45 | +63.0% |
| FY2017 | $0.28 | +24.6% |
| FY2016 | $0.22 | -44.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026